These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1027 related articles for article (PubMed ID: 19440012)
1. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection. Chiang IN; Chang SJ; Pu YS; Huang KH; Yu HJ; Huang CY Urol Int; 2009; 82(3):270-5. PubMed ID: 19440012 [TBL] [Abstract][Full Text] [Related]
2. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer]. Iwaki H; Kajita Y; Shimizu Y; Yamauchi T Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957 [TBL] [Abstract][Full Text] [Related]
3. Free PSA/total PSA ratio increases the detection rate of prostate cancer in twelve-core biopsy. Yokomizo Y; Miyoshi Y; Nakaigawa N; Makiyama K; Ogawa T; Yao M; Kubota Y; Uemura H Urol Int; 2009; 82(3):280-5. PubMed ID: 19440014 [TBL] [Abstract][Full Text] [Related]
4. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density. Men S; Cakar B; Conkbayir I; Hekimoglu B J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539 [TBL] [Abstract][Full Text] [Related]
5. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence. Rahardjo D; Kamil ST; Pakasi LS Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():563-70. PubMed ID: 10895211 [TBL] [Abstract][Full Text] [Related]
6. The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men. Akduman B; Alkibay T; Tuncel A; Bozkirli I Can J Urol; 2000 Oct; 7(5):1104-9. PubMed ID: 11114873 [TBL] [Abstract][Full Text] [Related]
7. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men. Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M Urol J; 2009; 6(3):182-8. PubMed ID: 19711272 [TBL] [Abstract][Full Text] [Related]
8. Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels. Tanaka N; Fujimoto K; Chihara Y; Torimoto M; Hirao Y; Konishi N; Saito I Prostate Cancer Prostatic Dis; 2007; 10(3):274-8. PubMed ID: 17339878 [TBL] [Abstract][Full Text] [Related]
9. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer. Kubota Y; Kamei S; Nakano M; Ehara H; Deguchi T; Tanaka O Int J Urol; 2008 Apr; 15(4):322-6; discussion 327. PubMed ID: 18380820 [TBL] [Abstract][Full Text] [Related]
10. PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases. Aksoy Y; Oral A; Aksoy H; Demirel A; Akcay F Ann Clin Lab Sci; 2003; 33(3):320-3. PubMed ID: 12956448 [TBL] [Abstract][Full Text] [Related]
11. Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer? Ohori M; Dunn JK; Scardino PT Urology; 1995 Nov; 46(5):666-71. PubMed ID: 7495118 [TBL] [Abstract][Full Text] [Related]
12. Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for T1c prostate cancer. Tanaka N; Fujimoto K; Yoshikawa M; Tanaka M; Hirao Y; Kondo H; Saito I Hinyokika Kiyo; 2007 Jul; 53(7):459-65. PubMed ID: 17702178 [TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting. Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022 [TBL] [Abstract][Full Text] [Related]
14. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients. Guichard G; Larré S; Gallina A; Lazar A; Faucon H; Chemama S; Allory Y; Patard JJ; Vordos D; Hoznek A; Yiou R; Salomon L; Abbou CC; de la Taille A Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489 [TBL] [Abstract][Full Text] [Related]
15. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution. Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809 [TBL] [Abstract][Full Text] [Related]
16. Prostate specific antigen density can help avoid unnecessary prostate biopsies at prostate specific antigen range of 4-10 ng/ml. Lodeta B; Benko G; Car S; Filipan Z; Stajcar D; Dujmović T Acta Clin Croat; 2009 Jun; 48(2):153-5. PubMed ID: 19928413 [TBL] [Abstract][Full Text] [Related]
17. The value of free and total prostate specific antigen in identifying patients for prostatic biopsy and its relationship to Gleason score and number of positive cores. Bulbul MA; Khauli RB; Nasr R; Hemady K; Wazzan W J Med Liban; 2000; 48(2):59-62. PubMed ID: 11028151 [TBL] [Abstract][Full Text] [Related]
18. A higher PSA-density cut-off level in patients with intermediate PSA values for the early detection of prostate cancer. Mochtar CA; Rahardjo D; Umbas R Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():514-22. PubMed ID: 10895203 [TBL] [Abstract][Full Text] [Related]
19. Prostate cancer detection by prostate-specific antigen-related parameters. Segawa N; Gohji K; Iwamoto Y; Ueda H; Katsuoka Y Hinyokika Kiyo; 2003 Jul; 49(7):405-10. PubMed ID: 12968483 [TBL] [Abstract][Full Text] [Related]
20. [Combined use of PSA density and free to total PSA ratio for cancer detection from patients with PSA elevations]. Kawai M; Okajima K; Kobayashi K; Moriyama M Hinyokika Kiyo; 2006 Feb; 52(2):113-7. PubMed ID: 16541764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]